| Date Filed | Type | Description |
| 03/29/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/10/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/04/2022 |
SC 13D/A
| Arix Bioscience plc reports a 5.6% stake in LogicBio Therapeutics, Inc. |
| 02/15/2022 |
SC 13D/A
| Arix Bioscience plc reports a 6.6% stake in LogicBio Therapeutics, Inc. |
| 02/10/2022 |
SC 13G/A
| Arix Bioscience plc has filed a Schedule 13D for Aura Biosciences, Inc. |
| 11/10/2021 |
SC 13G
| Arix Bioscience plc reports a 5.3% stake in Aura Biosciences, Inc. |
| 10/26/2021 |
SC 13D/A
| Arix Bioscience plc reports a 9.2% stake in LogicBio Therapeutics, Inc. |
| 07/20/2021 |
SC 13D/A
| Arix Bioscience plc reports a 9% stake in Imara Inc. |
| 07/15/2021 |
SC 13D/A
| Arix Bioscience plc reports a 6.7% stake in Harpoon Therapeutics, Inc. |
| 02/17/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/12/2021 |
SC 13D/A
| Arix Bioscience plc reports a 6.9% stake in Harpoon Therapeutics, Inc. |
| 01/08/2021 |
SC 13D/A
| Arix Bioscience plc reports a 6.1% stake in Imara Inc. |
| 01/08/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/04/2020 |
SC 13D/A
| Arix Bioscience plc reports a 8.4% stake in Imara Inc. |
| 09/29/2020 |
SC 13D/A
| Arix Bioscience plc reports a 10.1% stake in LogicBio Therapeutics, Inc. |
| 06/05/2020 |
SC 13D/A
| Arix Bioscience plc reports a 2.2% stake in Iterum Therapeutics plc |
| 06/01/2020 |
SC 13D/A
| Arix Bioscience plc reports a 8.8% stake in Harpoon Therapeutics, Inc. |
| 03/24/2020 |
SC 13D
| Arix Bioscience plc reports a 9.4% stake in Imara Inc. |
| 01/27/2020 |
SC 13D/A
| Arix Bioscience plc reports a 7.4% stake in Iterum Therapeutics plc |
| 12/11/2019 |
SC 13D/A
| Arix Bioscience plc reports a 10.6% stake in Harpoon Therapeutics, Inc. |
| 02/22/2019 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 11/02/2018 |
SC 13D
| Arix Bioscience plc reports a 13% stake in LogicBio Therapeutics, Inc. |
| 07/06/2018 |
SC 13D
| Arix Bioscience plc reports a 7.9% stake in Autolus Therapeutics plc |
| 06/11/2018 |
SC 13D
| Arix Bioscience plc reports a 7.4% stake in Iterum Therapeutics plc |